BRCA2 and hypoparathyroidism-retardation-dysmorphism syndrome: Additionally, three cases were notable for homologous recombination deficiency (HRD) as indicated by pathogenic variants in BRCA1 and/or BRCA2, or a high genomic scar score that combines genomic loss of heterozygous (gLOH) with large-scale state transitions (LST).